Oversight and Investigations

Chairman:  Tim Murphy (PA-18)
Responsibility for oversight of agencies, departments, and programs related to the jurisdiction of the full committee, and for conducting investigations.



Tim Murphy (PA), Chairman
David McKinley (WV), Vice Chairman
Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Morgan Griffith (VA)
Larry Bucshon (IN)
Bill Flores (TX)
Susan Brooks (IN)
Markwayne Mullin (OK)
Richard Hudson (NC)
Chris Collins (NY)
Kevin Cramer (ND)
Joe Barton (TX)
Fred Upton (MI) (Ex Officio)


Diana DeGette (CO), Ranking Member
Jan Schakowsky (IL)
Kathy Castor (FL)
Paul Tonko (NY)
John Yarmuth (KY)
Yvette D. Clarke (NY)
Joseph P. Kennedy, III (MA)
Gene Green (TX)
Peter Welch (VT)
Frank Pallone, Jr. (NJ) (Ex Officio)

May 28, 2015 | Letter

Excerpt: In the event of a violation of the Federal Food, Drug, and Cosmetic Act, FDA may give individuals and firms an opportunity to take voluntary and prompt action to correct the violation before the FDA initiates an enforcement action.

May 26, 2015 | Press Release

The Subcommittee on Oversight and Investigations, chaired by Rep. Tim Murphy (R-PA), has scheduled a hearing for Tuesday, June 2, at 10:15 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled, “Medicaid Program Integrity: Screening Out Errors, Fraud, and Abuse.”

May 21, 2015 | Press Release

WASHINGTON, DC – The Energy and Commerce Oversight and Investigations Subcommittee, chaired by Rep.

May 19, 2015 | Press Release

WASHINGTON, DC – The House Energy and Commerce Committee today continued its investigation into the handling of select agents at federal laboratories.

May 19, 2015 | Letter

Excerpt: We believe the information and evidence developed from this investigation provides a basis to believe that there were additional lapses and concerns involved with the retention of the smallpox samples than just the failure to account for undiscovered, and presumably abandoned, materials.